共 50 条
- [31] Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal modelsNATURE COMMUNICATIONS, 2023, 14 (01)Corleis, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany论文数: 引用数: h-index:机构:Rauch, Susanne论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyFricke, Charlie论文数: 0 引用数: 0 h-index: 0机构: Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyRoth, Nicole论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyGergen, Janina论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyKovacikova, Kristina论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Schoen, Jacob论文数: 0 引用数: 0 h-index: 0机构: Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany论文数: 引用数: h-index:机构:Widera, Marek论文数: 0 引用数: 0 h-index: 0机构: Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany论文数: 引用数: h-index:机构:Mueller, Stefan O.论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyMettenleiter, Thomas C.论文数: 0 引用数: 0 h-index: 0机构: Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyMaione, Domenico论文数: 0 引用数: 0 h-index: 0机构: GSK, Siena, Italy Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyPetsch, Benjamin论文数: 0 引用数: 0 h-index: 0机构: CureVac SE, Tubingen, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, GermanyBeer, Martin论文数: 0 引用数: 0 h-index: 0机构: Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany论文数: 引用数: h-index:机构:
- [32] Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 VariantsMICROBIOLOGY SPECTRUM, 2022, 10 (05):Cheng, Hoi Lok论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeLim, Sing Mei论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeJia, Huan论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeChen, Ming Wei论文数: 0 引用数: 0 h-index: 0机构: Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeNg, Say Yong论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeGao, Xiaohong论文数: 0 引用数: 0 h-index: 0机构: Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeSomani, Jyoti论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore Hosp, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeSengupta, Sharmila论文数: 0 引用数: 0 h-index: 0机构: Natl Univ Singapore Hosp, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeTay, Dousabel M. Y.论文数: 0 引用数: 0 h-index: 0机构: MIT, Dept Chem Engn, Cambridge, MA 02139 USA Singapore MIT Alliance Res & Technol, Singapore, SingaporeChua, Patrina W. L.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeAbirami, R.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeLing, Sharon Y. H.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeMcBee, Megan E.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeYoung, Barnaby E.论文数: 0 引用数: 0 h-index: 0机构: Natl Ctr Infect Dis, Singapore, Singapore Tan Tock Seng Hosp, Singapore, Singapore Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, SingaporeSikes, Hadley D.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, Singapore, Singapore MIT, Dept Chem Engn, Cambridge, MA 02139 USA Singapore MIT Alliance Res & Technol, Singapore, SingaporePreiser, Peter R.论文数: 0 引用数: 0 h-index: 0机构: Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore Singapore MIT Alliance Res & Technol, Singapore, Singapore
- [33] Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approachINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 162 : 820 - 837Ahammad, Ishtiaque论文数: 0 引用数: 0 h-index: 0机构: North South Univ, Dept Biochem & Microbiol, Dhaka 1229, Bangladesh North South Univ, Dept Biochem & Microbiol, Dhaka 1229, Bangladesh论文数: 引用数: h-index:机构:
- [34] A novel mRNA vaccine, SYS6006, against SARS-CoV-2FRONTIERS IN IMMUNOLOGY, 2023, 13Xu, Ke论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaLei, Wenwen论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaKang, Bin论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaYang, Hanyu论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaWang, Yajuan论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaLu, Yanli论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaLv, Lu论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaSun, Yufei论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaZhang, Jing论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaWang, Xiaolin论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaYang, Mengjie论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaDan, Mo论文数: 0 引用数: 0 h-index: 0机构: CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China CSPC Pharmaceut Grp Co Ltd, State Key Lab Novel Pharmaceut Preparat & Excipien, Shijiazhuang, Hebei, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R ChinaWu, Guizhen论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China
- [35] Research progress on vaccine efficacy against SARS-CoV-2 variants of concernHUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)Bian, Lianlian论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaLiu, Jianyang论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaGao, Fan论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaGao, Qiushuang论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaHe, Qian论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaMao, Qunying论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaWu, Xing论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaXu, Miao论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R ChinaLiang, Zhenglun论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China Natl Inst Food & Drug Control, Inst Biol Prod, Div Hepatitis & Enterovirus Vaccines, Beijing, Peoples R China
- [36] A potent, broadly protective vaccine against SARS-CoV-2 variants of concernnpj Vaccines, 7Ziyan Wang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyJiao An论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyKunpeng Liu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyPin Yu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyXin Fang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyJiadai Li论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyHua Zhu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyQianjun Zhu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyChuanqi Huang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyChao Zhang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyBinbin Zhao论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyLinlin Bao论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyYujiao Song论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyXiayao Cao论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyDongdong Hu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyYuanxiang Jiang论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyLikang Shi论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyLingyun Zhou论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyJiang Fan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyWuxiang Guan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyChenliang Zhou论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyZhongyu Hu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyZhiming Yuan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyJiangning Liu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyChao Shan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of VirologyGe Liu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Zerun Biotech Co.,State Key Laboratory of Virology, Wuhan Institute of Virology
- [37] Immediate reactions after administration of an mRNA vaccine against SARS-CoV-2CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (03) : E106 - E107Jeimy, Samira论文数: 0 引用数: 0 h-index: 0机构: Univ Western, Dept Med, Div Immunol Clin & Allergol, London, ON, Canada Univ Western, Dept Med, Div Immunol Clin & Allergol, London, ON, CanadaWong, Tiffany论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Dept Pediat, Div Allergol & Immunol, Vancouver, BC, Canada Univ Western, Dept Med, Div Immunol Clin & Allergol, London, ON, CanadaSong, Christine论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Dept Med, Div Immunol Clin & Allergol, Toronto, ON, Canada Univ Western, Dept Med, Div Immunol Clin & Allergol, London, ON, Canada
- [38] Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging VariantsBIOENGINEERING-BASEL, 2023, 10 (02):Zhang, Jianzhong论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R ChinaXia, Yutian论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R ChinaLiu, Xuan论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R ChinaLiu, Gang论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China
- [39] Challenges and developments in universal vaccine design against SARS-CoV-2 variantsnpj Vaccines, 7Fangxin Zhao论文数: 0 引用数: 0 h-index: 0机构: Beijing Institute of Biotechnology,Laboratory of Vaccine and Antibody EngineeringXiaodong Zai论文数: 0 引用数: 0 h-index: 0机构: Beijing Institute of Biotechnology,Laboratory of Vaccine and Antibody EngineeringZhiling Zhang论文数: 0 引用数: 0 h-index: 0机构: Beijing Institute of Biotechnology,Laboratory of Vaccine and Antibody EngineeringJunjie Xu论文数: 0 引用数: 0 h-index: 0机构: Beijing Institute of Biotechnology,Laboratory of Vaccine and Antibody EngineeringWei Chen论文数: 0 引用数: 0 h-index: 0机构: Beijing Institute of Biotechnology,Laboratory of Vaccine and Antibody Engineering
- [40] Challenges and developments in universal vaccine design against SARS-CoV-2 variantsNPJ VACCINES, 2022, 7 (01)Zhao, Fangxin论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China Zhejiang Univ, Sch Med, Hangzhou 310058, Peoples R China Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R ChinaZai, Xiaodong论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R ChinaZhang, Zhiling论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R ChinaXu, Junjie论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R ChinaChen, Wei论文数: 0 引用数: 0 h-index: 0机构: Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 10071, Peoples R China